<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01171495</url>
  </required_header>
  <id_info>
    <org_study_id>CHRC 51016</org_study_id>
    <nct_id>NCT01171495</nct_id>
  </id_info>
  <brief_title>Impact of Nutrition Intervention on HIV/AIDS Infected Patients</brief_title>
  <acronym>INI</acronym>
  <official_title>Phase 3 Study That Assesses the Impact of a Nutrition Intervention on HIV/AIDS Infected Patients: Kingston, Jamaica</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Caribbean Health Research Council</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The University of The West Indies</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Caribbean Health Research Council</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intervention to investigate the efficacy of a nutritional supplement among ARV-naïve,
      asymptomatic HIV positive patients with a CD4 count in the range 300-550 cells/ul.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To investigate the efficacy of a nutritional supplement among ARV-naïve, asymptomatic HIV
      positive patients with a CD4 count in the range 300-550 cells/ul.

      A total of 120 participants will be stratified by age and gender and randomly assigned to two
      treatment arms. Sixty (60) participants will be assigned to receive dietary counselling and a
      multivitamin/mineral supplement, with sixty (60) additionally receiving an oral Medical
      Nutritional Supplement (MNS).

      Participants will be followed for six months post-randomization: at baseline, 3 months and 6
      months. The principal outcome measure is Body Mass Index, used as a proxy for 'nutritional
      status'. Secondary outcome measures include immune status and antioxidant status.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2008</start_date>
  <completion_date type="Actual">August 2009</completion_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effects of nutritional intervention on anthropometry in HIV infected individuals.</measure>
    <time_frame>6 months</time_frame>
    <description>Body Mass Index</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effects of nutritional intervention on the clinical and immune status in HIV infected individuals.</measure>
    <time_frame>6 months</time_frame>
    <description>Immune status (CD4 cell count, total lymphocyte count), antioxidant status.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">121</enrollment>
  <condition>Human Immunodeficiency Virus (HIV)</condition>
  <condition>Acquired Immune Deficiency Syndrome (AIDS)</condition>
  <arm_group>
    <arm_group_label>Ensure Plus + Multivitamin/Counselling</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Multivitamin/Counselling</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Theragran-M; Ensure Plus</intervention_name>
    <description>Theragran-M: One tablet daily for 6-months. Ensure Plus: One 8 fl.oz. bottle daily for 6-months. Nutritional counselling: at baseline, and at monthly follow-up visits.</description>
    <arm_group_label>Ensure Plus + Multivitamin/Counselling</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Theragran-M</intervention_name>
    <description>Theragran-M: One tablet daily for 6-months. Nutritional counselling: at baseline and at monthly follow-up visits.</description>
    <arm_group_label>Multivitamin/Counselling</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  HIV positive individuals in the age range 18 to 50 years.

          -  Individuals whose CD4 count was between 300-550 cells/uL.

          -  Individuals who met the study criteria and were interested in being enrolled.

          -  Individuals not on ARV therapy.

          -  Women who were not pregnant.

        Exclusion Criteria:

          -  On the clinician's advice, individuals could be excluded from enrollment.

          -  Individuals who were unable to carry out the study intervention e.g. homeless,
             impaired mental state etc.

          -  Individuals who were unlikely to complete follow-up based on pre-enrolment assessment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sharon M Dawson, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of the West Indies, Mona ,Jamaica, West Indies</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Comprehensive Health Centre</name>
      <address>
        <city>Kingston</city>
        <country>Jamaica</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Jamaica</country>
  </location_countries>
  <verification_date>February 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 27, 2010</study_first_submitted>
  <study_first_submitted_qc>July 27, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 28, 2010</study_first_posted>
  <last_update_submitted>July 27, 2010</last_update_submitted>
  <last_update_submitted_qc>July 27, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2010</last_update_posted>
  <responsible_party>
    <name_title>Sharon Dawson</name_title>
    <organization>Ministry of Health,Kingston, Jamaica and The University of the West Indies, Mona, Jamaica</organization>
  </responsible_party>
  <keyword>HIV/AIDS</keyword>
  <keyword>Nutrition Therapy</keyword>
  <keyword>Dietary Supplement</keyword>
  <keyword>Antioxidant</keyword>
  <keyword>Immunity</keyword>
  <keyword>CD4 count</keyword>
  <keyword>Anthropometry</keyword>
  <keyword>Body Mass Index</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Immunologic Deficiency Syndromes</mesh_term>
    <mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

